Hound Labs, creator of the HOUND cannabis breathalyzer, announced an agreement with Quest Diagnostics, the world's leading provider of diagnostic information services. The agreement establishes Quest as the exclusive provider of laboratory services for confirmatory testing of positive breath sample results generated by the HOUND cannabis breathalyzer, used by employers on location as an objective measure to detect and deter cannabis use during the workday.
The HOUND identifies cannabis used within hours of testing and automatically processes results on-location within minutes. Negative test results indicate an employee is not likely to have used cannabis immediately preceding or during the workday. Under the terms, Quest Diagnostics will use a novel mass spectrometry technique it recently developed and validated at its Lenexa, KS, laboratory to confirm positive results from the Hound solution. Quest’s new technique is designed to match the level of sensitivity developed by Hound Labs to detect THC, the principal psychoactive compound in cannabis, in breath samples.
Hound Labs will begin delivering the HOUND in late 2022.